1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Raghothama, S. Simpson, P.J. Gilbert, H.J. Williamson, M.P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 39 978 10.1021/BI992163+ 10653641 Solution Structure of the Cbm10 Cellulose Binding Module from Pseudomonas Xylanase A 2000 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5400.007 ENDO-1,4-BETA-XYLANASE 3.2.1.8 TYPE X CELLULOSE BINDING DOMAIN (CBDX) 1 man polymer no no MGNQQCNWYGTLYPLCVTTTNGWGWEDQRSCIARSTCAAQPAPFGIVGSG MGNQQCNWYGTLYPLCVTTTNGWGWEDQRSCIARSTCAAQPAPFGIVGSG A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 294 PSEUDOMONAS FLUORESCENS 562 ESCHERICHIA COLI PLASMID BL21 repository Initial release Version format compliance Version format compliance 1 0 2000-10-03 1 1 2011-05-08 1 2 2011-07-13 2000-10-03 SPRSDE CATALYTIC CORE OF XYLANASE A SOLUTION STRUCTURE OF TYPE X CBD SOLUTION STRUCTURE OF TYPE X CBM HELIX DETERMINATION METHOD: AUTHOR PROVIDED. SHEET DETERMINATION METHOD: AUTHOR PROVIDED. PDBE Y PDBE 2000-09-28 REL THE STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES. 5 STRUCTURES CHOSEN AT RANDOM FROM THE 21 LOWEST ENERGY STRUCTURES 50 5 2D NOESY DQF-COSY E-COSY 100MM NACL 4.50 pH AMBIENT 323.00 K YASAP DISTANCE GEOMETRY, SIMULATED ANNEALING 1MM CBDX 50MM SODIUM PHOSPHATE BUFFER 100MM SODIUM CHLORIDE BRUNGER refinement X-PLOR 3.1 structure solution FELIX 97.0 structure solution X-PLOR 3.1 500 Bruker DRX 600 Bruker DRX MET 20 n 1 MET 20 A GLY 21 n 2 GLY 21 A ASN 22 n 3 ASN 22 A GLN 23 n 4 GLN 23 A GLN 24 n 5 GLN 24 A CYS 25 n 6 CYS 25 A ASN 26 n 7 ASN 26 A TRP 27 n 8 TRP 27 A TYR 28 n 9 TYR 28 A GLY 29 n 10 GLY 29 A THR 30 n 11 THR 30 A LEU 31 n 12 LEU 31 A TYR 32 n 13 TYR 32 A PRO 33 n 14 PRO 33 A LEU 34 n 15 LEU 34 A CYS 35 n 16 CYS 35 A VAL 36 n 17 VAL 36 A THR 37 n 18 THR 37 A THR 38 n 19 THR 38 A THR 39 n 20 THR 39 A ASN 40 n 21 ASN 40 A GLY 41 n 22 GLY 41 A TRP 42 n 23 TRP 42 A GLY 43 n 24 GLY 43 A TRP 44 n 25 TRP 44 A GLU 45 n 26 GLU 45 A ASP 46 n 27 ASP 46 A GLN 47 n 28 GLN 47 A ARG 48 n 29 ARG 48 A SER 49 n 30 SER 49 A CYS 50 n 31 CYS 50 A ILE 51 n 32 ILE 51 A ALA 52 n 33 ALA 52 A ARG 53 n 34 ARG 53 A SER 54 n 35 SER 54 A THR 55 n 36 THR 55 A CYS 56 n 37 CYS 56 A ALA 57 n 38 ALA 57 A ALA 58 n 39 ALA 58 A GLN 59 n 40 GLN 59 A PRO 60 n 41 PRO 60 A ALA 61 n 42 ALA 61 A PRO 62 n 43 PRO 62 A PHE 63 n 44 PHE 63 A GLY 64 n 45 GLY 64 A ILE 65 n 46 ILE 65 A VAL 66 n 47 VAL 66 A GLY 67 n 48 GLY 67 A SER 68 n 49 SER 68 A GLY 69 n 50 GLY 69 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N CYS 25 A N CYS 6 A O TYR 32 A O TYR 13 A O PRO 33 A O PRO 14 A N ILE 51 A N ILE 32 A O CYS 50 A O CYS 31 A N GLY 43 A N GLY 24 1 A ARG 48 0.203 SIDE CHAIN 1 A ARG 53 0.317 SIDE CHAIN 2 A ARG 48 0.207 SIDE CHAIN 2 A ARG 53 0.309 SIDE CHAIN 3 A ARG 48 0.279 SIDE CHAIN 3 A ARG 53 0.318 SIDE CHAIN 4 A ARG 48 0.222 SIDE CHAIN 4 A ARG 53 0.242 SIDE CHAIN 5 A ARG 48 0.195 SIDE CHAIN 5 A ARG 53 0.231 SIDE CHAIN 1 A ASN 26 -62.15 92.13 1 A TYR 28 37.73 26.01 1 A ASN 40 -82.72 41.46 1 A GLN 47 59.36 16.25 1 A ALA 52 -41.09 168.04 1 A ARG 53 -56.30 -79.06 1 A CYS 56 -72.67 -76.67 2 A TYR 28 37.25 27.00 2 A ASN 40 -84.10 43.50 2 A ALA 52 -41.97 167.85 2 A ARG 53 -58.19 -78.25 2 A CYS 56 -85.25 -74.06 2 A ALA 58 -90.36 31.66 3 A TYR 28 28.66 37.89 3 A ASN 40 -83.18 42.52 3 A GLN 47 59.87 19.30 3 A ALA 52 -40.32 165.41 3 A ARG 53 -57.22 -77.45 3 A CYS 56 -84.14 -76.13 3 A SER 68 -123.92 -151.14 4 A ASN 26 -59.95 93.58 4 A TYR 28 35.05 29.69 4 A ASN 40 -82.63 41.21 4 A GLN 47 58.88 16.87 4 A ALA 52 -41.75 168.18 4 A ARG 53 -56.46 -79.06 4 A CYS 56 -72.24 -76.75 5 A TRP 27 -68.97 95.01 5 A TYR 28 31.85 32.60 5 A ASN 40 -82.64 41.43 5 A GLN 47 59.29 16.50 5 A ALA 52 -40.46 166.07 5 A ARG 53 -56.27 -77.75 5 A CYS 56 -76.51 -75.49 5 A GLN 59 -44.85 161.58 ENDO-1,4-BETA-XYLANASE (E.C.3.2.1.8) SOLUTION STRUCTURE OF TYPE X CBD 1 N N A ARG 53 A ARG 34 HELX_P A ALA 57 A ALA 38 1 1 5 disulf 2.008 A CYS 25 A SG CYS 6 1_555 A CYS 56 A SG CYS 37 1_555 disulf 2.021 A CYS 35 A SG CYS 16 1_555 A CYS 50 A SG CYS 31 1_555 HYDROLASE HYDROLASE, BETA STRANDS, ANTIPARALLEL SHEETS A ALA 61 A ALA 42 1 A PRO 62 A PRO 43 0.26 A ALA 61 A ALA 42 2 A PRO 62 A PRO 43 0.11 A ALA 61 A ALA 42 3 A PRO 62 A PRO 43 -0.04 A ALA 61 A ALA 42 4 A PRO 62 A PRO 43 0.28 A ALA 61 A ALA 42 5 A PRO 62 A PRO 43 -0.16 XYNA_PSEFL UNP 1 P14768 179 228 1E8R 20 69 P14768 A 1 1 50 1 SER cloning artifact MET 20 1E8R A S06047 PIR 179 1 4 anti-parallel parallel anti-parallel A GLN 24 A GLN 5 A ASN 26 A ASN 7 A LEU 31 A LEU 12 A CYS 35 A CYS 16 A ARG 48 A ARG 29 A ALA 52 A ALA 33 A TRP 42 A TRP 23 A GLU 45 A GLU 26 1 P 1